Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Apr 28, 2010; 16(16): 1986-1992
Published online Apr 28, 2010. doi: 10.3748/wjg.v16.i16.1986
Table 1 Demographic data of 298 patients with advanced esophageal cancer n (%)
VariablesSurgery aloneNeoadjuvantCRTSignificance
Patients108190
SexNS
Male86 (80.0)151 (79.4)
Female22 (20.0)39 (20.6)
Age (yr)63.660.1P < 0.01
< 5011 (10.2)38 (20.0)
50-7065 (60.2)124 (65.3)
> 7032 (29.6)18 (14.7)
Histological subtype0.871
Squamous cell carcinoma55 (51.0)100 (52.6)
Adenocarcinoma53 (49.0)90 (47.4)
No. of resected LNs (median, range)30 (3-74)27 (4-55)P = 0.007
pN categoryP < 0.001
pN027 (25.0)98 (51.6)
pN181 (75.0)92 (48.5)
LN ratioP < 0.001
pN027 (25.0)98 (51.6)
LN ratio < 0.252 (48.1)69 (36.3)
LN ratio ≥ 0.229 (26.9)23 (12.1)
pM1 organ11 (10.1)8 (4.2)NS
R categoryNS
R098 (92.6)179 (94.2)
R1/R210 (7.4)11 (5.8)
Response after neoadjuvant therapy
Minor response-112 (59.0)
Major response-78 (41.0)